CASTLEVAX INC
NEW YORK, NEW YORK 100144604
$8.29M
Total Contract Value
7 awards
First Award
Sep 27, 2023
Last Award
Aug 20, 2024
Business Size
other than small
CAGE Code
9M4Y5
Top Industries (NAICS)
| NAICS Code | Obligations | Awards |
|---|---|---|
| 541714 | $8.29M | 7 |
Contract Awards
2 awards found
75A50123C00065
Department of Health and Human Services
$-103,934
Aug 20, 2024
THE PURPOSE OF THIS MODIFICATION IS TO UPDATE SECTION J, ATTACHMENT #1 ? STATEMENT OF WORK TO REMOVE WBS 1.2.10.6, 1.2.10.7 AND UPDATE ATTACHMENT #9, PART I DELIVERABLES AND BARDA MILESTONE PAYMENT SCHEDULE. THE OVERALL CONTRACT VALUE IS REDUCED FROM
NAICS: 541714 - RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)FY2024
75A50123C00065
Department of Health and Human Services
$8.40M
Sep 27, 2023
DEVELOP A NEXT-GENERATION, MUCOSALLY DELIVERED, COVID-19 BOOSTER VACCINE CAPABLE OF ELICITING MUCOSAL IMMUNITY AND PROTECTING AGAINST SARS-COV-2 BREAKTHROUGH INFECTION AND TRANSMISSION
NAICS: 541714 - RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)FY2023
Business Details
- UEI
- FLZ6THBQ53N3
- CAGE Code
- 9M4Y5
- Address
- 175 VARICK ST RM 608
NEW YORK, NY 100144604 - Congressional District
- NY-10
- Phone
- 8474006980
Parent Company
CASTLEVAX INC
Data Source
This profile is based on federal contract award data from USAspending.gov.
View on USAspending.gov